Nu Skin Enterprises, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Nu Skin Enterprises, Inc. (NYSE: NUS) is a global direct-selling company that develops, manufactures, and markets beauty, personal care, and nutritional supplements through a network of approximately 1.2 million independent distributors in 54 markets worldwide, including the Americas, Asia-Pacific, and Europe, the Middle East, and Africa. Founded in 1984 and headquartered in Provo, Utah, the company operates under the Nu Skin and Pharmanex brands, offering anti-aging skincare such as ageLOC series including Tru Face, LumiSpa, and LumiSpa iO; beauty devices like RenuSpa iO, an FDA-cleared microcurrent body device, Facial Spa, Galvanic Spa, and GloPRO Microneedling Tool; cosmetics and hair care products including Nu Colour Lash + Brow; Nutricentials Bioadaptive Skin Care; targeted wellness supplements like LifePak multivitamins, Nu Biome for gut health, and MYND360 for cognitive support with sleep, focus, and stress management formulas; oral care, body care, facial cleansers, moisturizers, and weight management solutions such as TR90; Epoch natural-ingredient products; and emerging connected devices under the IO platform including the upcoming Prysm iO intelligent beauty and wellness system. Recent developments include the January 2025 sale by its Rhyz Inc. subsidiary of the Mavely affiliate marketing platform to Later for approximately $250 million in cash and equity; the October 2024 launch of MYND360 cognitive health line following five years of research; the February 2024 introduction of RenuSpa iO as its first integrated beauty and wellness device; a June 2025 relaunch of ageLOC Tru Face with sustainable packaging; the June 2025 appointment of James Winett to its board; and strategic priorities for 2025 emphasizing core business strengthening, IO platform acceleration including RISE, and developing markets expansion such as into India, alongside recognition as the world's top beauty and wellness device systems company by Euromonitor for 2025.
July Graham Value All-Stars (GVAS) Emit 10 Beaming Buys
20 July Ideal 'Safer' Russell Index Buys You Might Choose To Hold Forever
5 Undervalued Stocks With Attractive Price-to-Sales Ratios
Nu Skin Enterprises: Working Capital Intensity, A Lot Riding On India
5 Beauty & Cosmetics Stocks to Buy for a Stable Portfolio in 2H 2026
Nu Skin (NUS) Soars 6.9%: Is Further Upside Left in the Stock?
4 Cosmetics Stocks Worth Watching on Favorable Industry Trends
5 Value Stocks With Low Price-to-Sales Ratios & Massive Upside
13 Lucky Dogs: June Graham Value All-Stars (GVAS)
5 Bargain Low Price-to-Sales Stocks Positioned to Deliver Solid Gains
5 Value Stocks Trading at Attractive Price-to-Sales Ratios
3 Cosmetics Stocks Gaining From AI, Wellness and Innovation Trends
Nu Skin Reaches 900 Million Meals Purchased and Donated in its Global Fight for Child Nutrition
Nu Skin Enterprises Q1 Earnings Call Highlights
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 1Q26
Nu Skin Enterprises, Inc. (NUS) Q1 2026 Earnings Call Transcript
Nu Skin Enterprises (NUS) Q1 Earnings and Revenues Lag Estimates
Nu Skin Enterprises Reports First Quarter Results
Nu Skin Enterprises Announces Quarterly Dividend
Buy 14 Ideal Graham Value All-Stars Of 27 'Safer' Dividends In 71 April/May GVAS